Latest News
31-Jul-2026 Piramal Pharma Bets on its Global Operations
24-Jul-2026 Jackson Labs Seeks Restoration of its Licences
24-Jul-2026 ‘Yurpeak Sales Growing, in No Hurry to Launch Semaglutide’
23-Jul-2026 Trump Prescribes New Pill; India Side Effects Unlikely
23-Jul-2026 DRL Net Falls 69%; Expects to Resume Supplies of Generic Semaglutide by Nov
  more...
Latest Reports
Jul-26 Pharma Weekly - ICYMI - Emkay Research  
Jul-26 Pharma Weekly - ICYMI - Emkay Research  
Jul-26 A Paradigm Shift in Diabetes Care - Nirmal Bang  
Jul-26 Q1 to see strong India, muted US, margin pressure - HDFC Securities  
Jul-26 Another healthy quarter ahead - Emkay Research  
  more...

Quarterly Summary March-2026
Desc Current Previous Per.Chg
Sales 74642.3 76076.7 -1.9
Otherincome 3949.5 2779.7 42.1
Expense 57617.7 54983.3 4.8
RawMaterial 22040.3 20989.5 5.0
StaffCost 11711.1 10695.2 9.5
ExciseDuty 31.3 83.8 -62.7
OtherExp 17733.9 16934.6 4.7
Interest 1476.2 1361.8 8.4
GrossProfit 22124.9 23658.9 -6.5
Depreciation 3341.1 3112.3 7.4
Tax 3279.3 4641.5 -29.3
NetProfit 15019.1 16209.0 -7.3
Total.Comp 189 -- --
Source: ETIG Database

Sectoral Companies As on 3 Aug 2026
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 467863.50
Divi's Lab 220930.05
Torrent Phar 169863.04
Cipla 118673.17
Zydus Life 111345.94
Lupin 108642.60
Mankind Phar 102194.79
Laurus Labs 97839.27
Dr.Reddy's 97651.55
Aurobindo Ph 92405.28
Biocon 68936.31
Alkem Labora 67940.27
Glenmark Pha 61480.09
  click here for the complete list